Search results

Evidence-based recommendations on methadone and buprenorphine (oral formulations) for managing opioid dependence in adults.

Result type

Technology appraisal guidance

Published

24 January 2007

Summary of the evidence on buprenorphine prolonged-release subcutaneous injection (Buvidal) for opioid dependence to inform local NHS

Result type

Evidence summary

Published

14 February 2019

This guideline covers helping adults and young people over 16 who are dependent on opioids to stop using drugs. It aims to reduce illicit drug use and improve people’s physical and mental health, relationships and employment.

Result type

Clinical guideline

Published

25 July 2007

This guideline covers safe and effective prescribing of strong opioids for pain relief in adults with advanced and progressive disease. It aims to clarify the clinical pathway for prescribing and help to improve pain management and patient safety. Care during the last 2 to 3 days of life is covered by NICE's guideline on care of dying adults in the last days of life .

Result type

Clinical guideline

Last updated

3 August 2016

May 2018 Morphine 93% Nov 2018 Buprenorphine 33% May 2018 Buprenorphine 93% Nov 2018 Warfarin prescribing where an...

Result type

Shared learning

Published

10 October 2019

This guideline covers using psychosocial interventions to treat adults and young people over 16 who have a problem with or are dependent on opioids, stimulants or cannabis. It aims to reduce illicit drug use and improve people’s physical and mental health, relationships and employment.

Result type

Clinical guideline

Published

25 July 2007

This guideline covers the diagnosis, assessment and non-surgical management of osteoarthritis. It aims to improve management of osteoarthritis and the quality of life for people with osteoarthritis.

Result type

NICE guideline

Published

19 October 2022

This quality standard covers managing acute painful episodes of sickle cell disease in hospital. It includes pain relief and care for children, young people and adults, from presentation in hospital until discharge. It describes high-quality care in priority areas for improvement.

Result type

Quality standard

Published

10 April 2014

This quality standard covers assessment and treatment of drug use disorders in adults (aged 18 and over). It includes treating the misuse of opioids, cannabis, stimulants and other drugs in all settings, including inpatient and specialist residential and community-based treatment settings, and prison services. It describes high-quality care in priority areas for improvement.

Result type

Quality standard

Published

19 November 2012